Innovation
34 patent families (15 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace dormant. Cited 806 times.
| Year | Filings |
|---|---|
| 2012 | 1 |
Investor mix
8 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Other / undisclosed | 8 | 100% |
5HT3 receptor-targeted drugs for bowel syndromes
34 patent families (15 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace dormant. Cited 806 times.
| Year | Filings |
|---|---|
| 2012 | 1 |
8 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Other / undisclosed | 8 | 100% |